Background: Since 1987, a nationwide annual survey of percutaneous cardiac interventions is performed in Switzerland in order to assess trends with respect to type and frequency of endovascular cardiac procedures.
Introduction
Since 1987, a nationwide survey of interventional procedures in all Swiss cardiology centres is performed annually [1, 2] in order to asses trends with respect to type and frequency of endovascular cardiac procedures. In particular, we were interested to identify whether studies on controversial topics, including percutaneous coronary intervention (PCI) in patients with stable coronary artery disease and the use of drug-eluting stents (DES) published in 2006/2007 may have influenced the volume of procedures performed in 2007 compared to previous years. Thus, the aim of the present report was to provide cardiologists, primary care physicians, as well as the public health community, with the most recent data on interventional cardiology practice in the country.
Methods
Based on a standardised questionnaire [2] , all cardiology centres performing interventional procedures on adult patients were asked to report on procedures performed during the year 2007. The requested items included data about infrastructure, operators, availability of cardiac surgery, number of coronary angiographies (CA) and PCI, detailed information about the circumstances of PCI (ad hoc interventions, singlevessel vs multi-vessel PCI), types of stents [bare-metal stents (BMS) or DES], other revascularisation techniques (e.g., rotablator), adjunctive techniques such as use of distal protection devices, use of mechanical circulatory support, glycoprotein IIb/IIIa inhibitors, and complications. In addition, centres were asked to report interventions for structural heart disease such as balloon valvuloplasties or closure of ORIGINAL ARTICLE
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Interventional Cardiology in Switzerland during the Year 2007 intracardiac shunts. For the first time, we also collected information about the number of transcatheter aortic valve implantation (TAV I) procedures performed in 2007, although this was not an item on the initial questionnaire. The questionnaires were returned by all centres contributing data in the last years, although for some centres, information was not available for all items. One centre with interventional cardiology activity has not contributed data in previous years, and refused to participate in the current report (Lindenhofspital, Bern). The following definitions were applied: CA: diagnostic cardiac catheterisation for visualisation of the coronary arteries, independently whether or not an intervention is performed in the same session. The number of cases is recorded. PCI: coronary angioplasty with or without stent placement. If PCI is performed directly following the diagnostic procedure during the same session, it is referred to as ad hoc PCI. The number of cases, but not the number of vessels dilated, is recorded.
Results

Structure of Swiss centres
In 2007, there were 28 active centres (5 university, 10 public, non-university, 13 private hospitals), all of which performed both diagnostic procedures and PCI. At the beginning of 2007, the Cantonal Hospital in Fribourg opened a new cardiac catheterisation facility. As in the previous two years, the University Hospital Zürich (UniversitätsSpital Zürich; USZ), the Kantonsspital Winterthur (KSW) and the Spital Thurgau AG (Frauenfeld) were considered as a single centre, as there is an established collaboration between these hospitals. Among the 28 centres, 12 institutions had one catheterisation laboratory, 12 centres had two, three centres had three, and one centre (USZ/KSW/ Frauenfeld) performed procedures in five locally separated catheterisation laboratories. A total of 34 (2006: 64) operators performed exclusively diagnostic studies, whereas 138 (2006: 129) cardiologists performed both CA and PCI. In 18 centres, cardiac surgery was available on site. 
Coronary interventions
Coronary stents
The rate of stent utilisation was 91% (data not available from one centre; 2006: 89%). 
PCI for acute myocardial infarction
Complications after PCI
Myocardial infarction after PCI was reported in 1.0% of procedures (2006: 1.5%), emergency coronary artery bypass grafting was required in 0.2% of cases (2006: 0.2%), and mortality following PCI was reported to be 0.5% (2006: 0.6%). However, data on complications were not provided by five centres, and the broad range of myocardial infarction (0.5-2.9%) and mortality (0-2.6%) rates suggests that there were significant differences in the definitions of myocardial infarction (which Kardiovaskuläre Medizin 2010;13(1):18-24 was not given in the questionnaire) and in the scrutiny of clinical follow-up.
Non-coronary interventions
The number of balloon valvuloplasties ( fig. 7 ) did not differ markedly from previous years. For the first time in Switzerland, TAVI was performed in 2007 (n = 18; all procedures performed at the Inselspital Bern).
There was an increase in the number of procedures for PFO and atrial septal defect (ASD) closure ( fig. 8 ).
Other interventions for repair of structural defects included ventricular septal defect closure (n = 10) and patent ductus arteriosus closure (n = 8). In addition, 14 angioplasties/stenting for a coarctatio of the aorta were performed. 
Non-cardiac interventions
Discussion
The present survey provides important insights into temporal changes of invasive cardiac procedures in Switzerland. We observed the following main findings: (1.) a plateau in the number of PCI, (2.) a small decrease in the utilisation of DES, although they remained the most frequently used type of stent, (3.) an increase in the number of procedures for PFO and ASD closure, and (4.) the introduction of TAVI. The number of CA and PCI has flattened, and the number of PCI seems to have reached a plateau over the last years but did not decrease. It appears that the impact of studies comparing optimal medical treatment with PCI suggesting similar efficacy [3] had only a minor impact on daily practice. Moreover, revascularisation procedures, including PCI and coronary artery bypass grafting,r emain important therapeutic measures to alleviate ischaemia and have been repeatedly Kardiovaskuläre Medizin 2010;13(1):18-24 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 pulmonary valve aortic valve mitral valve shown to improve prognosis in patients with large areas of ischaemic myocardium. However, it must be pointed out that given the lack of detailed information on indications for PCI in our survey, this and the following reflections on the impact of comparatively recent data (published in 2006 or 2007 to have impact on activities reported in this survey) remain speculative, and caution is warranted not to over-interpret this data from a catheterisation lab-based questionnaire. Between the end of the study period and the publication of this report, "appropriateness criteria" for PCI 2007 [5] , the proportion of STEMI patients undergoing primary PCI has increased from 43% to 85% from 2000 to 2007, and the thrombolysis rate has decreased from 40% to 2%. This change in practice was associated with a reduction in in-hospital mortality from 7.6% to 6%, re-infarction from 3.7% to 0.9%, and stroke from 1.8% to 0.8% [5] . Another recently published analysis from the AMIS Plus registry [6] revealed a reduction in in-hospital mortality and a decrease in the incidence of cardiogenic shock during hospital stay,f ollowing acute coronary syndrome in Switzerland between 1997 and 2006. PCI was an independent predictor for both a lower all cause mortality in the overall population and a lower incidence of cardiogenic shock within the group of patients with acute coronary syndrome but without shock on admission, supporting the role of PCI in the acute setting.
In contrast to the evolution within the previous three years, the DES utilisation rate has decreased for the first time, and a similar trend was observed in Austria during the year 2007 [7] . The phenomenon of very late stent thrombosis after DES implantation [8] may have contributed to the more selective use of DES. However, no study has demonstrated an adverse effect of DES on survival [9] . Thus, given the benefit of DES in terms of reduced target lesion revascularisation [10, 11] a nd the similar outcome in terms of ischaemic adverse events, the proportion of DES is likely to increase again.
The number of balloon valvuloplasties did not change as compared to previous years. However, TAVI was introduced in Switzerland with the first procedures performed at the Inselspital in Bern [12] . Given the number of eligible patients for TAVI, additional centres have implemented this procedure, and the data will be updated regularly in future surveys.
Interestingly, the number of procedures for PFO closure showed a marked increase, after there had been no increase between 2005 and 2006. Indications for PFO closure are still under debate, and there is no consensus regarding optimal management of patients with PFO and stroke. It is widely accepted that young patients with recurrence of stroke, despite antithrombotic therapy,s hould undergo PFO closure [13] . In daily practice, PFO closure is typically performed more liberally in patients with cryptogenic stroke. It has been suggested that all high risk patients with cryptogenic stroke may benefit from PFO closure, in terms of prevention of recurrence [14] . The association between PFO with and without atrial septal aneurysm and stroke was initially accepted only for younger patients (<55 years). However, recent data from a large observational study suggest that such a relationship may also apply for older patients [15] , which might give rise to speculations about expanding indications for PFO closure. However, this study was published at the end of 2007 and thus, is unlikely to have significantly contributed to the practice in 2007. The results of ongoing prospective randomised trials comparing PFO closure with medical therapy (summarised in [16] ) are awaited and will hopefully more clearly define the role of PFO closure in patients with stroke. However, this trial recruits slowly, and referral bias is a concern [14, 16] . It also has to be considered that the increase in PFO closure procedures may,in part, have been due to indications other the secondary prevention after stroke, including PFO closure in divers or patients with migraine.
Limitations of the study
Data reporting was incomplete with respect to several items, and some centres were not prepared to present all of the data of interest. Accordingly, results must be interpreted cautiously. In addition, periprocedural complications are likely to be underreported due to detection bias. A catheterisation laboratory-based analysis is unlikely to be complete, and we can assume that only complications occurring immediately at the time of catheterisation have been included.
Conclusions
The number of CA and PCI has flattened over recent years. The use of DES remained high, although there was a decrease compared to the previous year. Procedures for percutaneous PFO and ASD closure are performed with increasing frequency.T ranscatheter aortic valve implantation was performed for the first time in Switzerland in 2007.
